收藏切换
Research progress on etomidate derivatives
收藏切换
Wei WANG1, Qu-xiang LI1, Shu-ming HU1, Xiang-qing XU1, 2, *
Acta Pharmaceutica Sinica | 2026, 61(3) : 738 - 748
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(3): 738-748
• Reviews •
Research progress on etomidate derivatives
Full
Wei WANG1, Qu-xiang LI1, Shu-ming HU1, Xiang-qing XU1, 2, *
Affiliations
  • 1Institute of Nhwa Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China
  • 2Jiangsu Key Laboratory of Central Nervous System Drug Research and Development, Xuzhou 221116, China
Published: 2026-03-12 doi: 10.16438/j.0513-4870.2025-0770
Outline
收藏切换

Since its introduction to the market, etomidate has held a significant position among intravenous anesthetics due to its favorable anesthetic properties and hemodynamic stability. However, adverse reactions like adrenocortical suppression and myoclonus have limited its clinical application. In recent years, the research on novel etomidate derivatives that can retain the excellent anesthetic characteristics of etomidate while significantly ameliorating its adverse effects has become a hot topic in the development of new anesthetic drugs. Through the structural modification of pharmacophores such as the carboxylic acid ester chain and imidazole ring, new derivatives, including ABP-700, EL-0052, ET-26, and NH600001, have been discovered. Some of these drugs have entered the phase Ⅲ clinical trial or NDA application stage, showing promising prospects for successful development and marketing approval. This article reviews the design strategies, preclinical research, and clinical research progress of etomidate derivatives, aiming to provide references for the development of new intravenous anesthetics.

intravenous anesthetics  /  etomidate derivative  /  adrenal cortex  /  myoclonus  /  CYP11B1
王伟, 李曲祥, 胡书明, 徐祥清. 依托咪酯衍生物研究进展. 药学学报, 2026 , 61 (3) : 738 -748 . DOI: 10.16438/j.0513-4870.2025-0770
Wei WANG, Qu-xiang LI, Shu-ming HU, Xiang-qing XU. Research progress on etomidate derivatives[J]. Acta Pharmaceutica Sinica, 2026 , 61 (3) : 738 -748 . DOI: 10.16438/j.0513-4870.2025-0770
Year 2026 volume 61 Issue 3
213
108
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0770
  • Receive Date:2025-07-05
  • Online Date:2026-09-21
  • Published:2026-03-12
Article Data
Affiliations
History
  • Received:2025-07-05
  • Revised:2025-08-15
Affiliations
    1Institute of Nhwa Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China
    2Jiangsu Key Laboratory of Central Nervous System Drug Research and Development, Xuzhou 221116, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0770
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT